Trauma and PTSD

Comprehensive tutorial on trauma-related disorders including PTSD, acute stress disorder, and complex trauma. DSM-5 diagnostic criteria, risk factors, neurobiology, and evidence-based treatments including EMDR, CPT, and PE.

This content is for informational purposes only. Always consult a healthcare professional.

Definitions and Core Concepts

Trauma refers to an event, series of events, or set of circumstances that is experienced as physically or emotionally harmful or life-threatening and that has lasting adverse effects on the individual’s functioning and mental, physical, social, emotional, or spiritual well-being (SAMHSA).

Trauma Types

Type Description Examples
Acute trauma Single, time-limited event Accident, assault, natural disaster, witnessing violence
Chronic trauma Repeated, prolonged events Ongoing abuse, domestic violence, war, captivity
Complex trauma Multiple, varied events, usually interpersonal and early-life Childhood abuse and neglect, prolonged maltreatment
Vicarious/secondary trauma Exposure to others’ trauma (professional or personal) First responders, therapists, family of trauma survivor
Historical/intergenerational Trauma transmitted across generations through systemic oppression Genocide, slavery, colonization, forced displacement
Developmental Trauma occurring during critical developmental periods Childhood trauma affecting brain development, attachment

Prevalence of Trauma Exposure

Population Lifetime Trauma Exposure
General population ~50-80%
Refugees ~90%+
Military veterans ~70-90% (combat exposure)
Survivors of interpersonal violence Variable (higher in certain populations)
First responders ~70-90% (repeated exposure)

Post-Traumatic Stress Disorder (PTSD)

PTSD is a psychiatric disorder that may occur in individuals who have experienced or witnessed a traumatic event involving actual or threatened death, serious injury, or sexual violence.

Epidemiology

Metric Value
Lifetime prevalence (US) ~6-8%
12-month prevalence (US) ~3-5%
Female:male ratio 2:1
Median age of onset ~23 years
Course Chronic in ~40% of cases
Remission rate (within 10 years) ~50%
Comorbidity rate ~80% have at least one comorbid disorder

DSM-5 Diagnostic Criteria

Criterion A: Exposure to actual or threatened death, serious injury, or sexual violence in one or more of the following ways:

  1. Directly experiencing the traumatic event(s)
  2. Witnessing, in person, the event(s) as it occurred to others
  3. Learning that the traumatic event(s) occurred to a close family member or close friend (violent or accidental)
  4. Experiencing repeated or extreme exposure to aversive details of the traumatic event(s) (professional exposure)

Criteria B-E (Symptoms):

Cluster Symptom Group Examples Number Required
B. Intrusion Recurrent, involuntary, intrusive memories; traumatic nightmares; flashbacks; intense distress at reminders; physiological reactivity “I can’t stop seeing it in my mind” 1+
C. Avoidance Avoidance of trauma-related thoughts, feelings, or external reminders (people, places, activities) “I don’t go anywhere that reminds me” 1+
D. Negative alterations in cognition and mood Inability to recall important aspects of trauma; persistent negative beliefs (world is dangerous, self is worthless); distorted blame; persistent negative emotions; loss of interest; detachment; inability to feel positive emotions “Nothing matters anymore; I feel dead inside” 2+
E. Alterations in arousal and reactivity Irritable/angry outbursts; reckless/self-destructive behavior; hypervigilance; exaggerated startle; concentration problems; sleep disturbance “I’m always on guard; every sound makes me jump” 2+

Additional criteria:

  • Duration: Symptoms persist for more than 1 month
  • Functional impairment: Symptoms cause clinically significant distress or impairment
  • Exclusion: Not attributable to substance use or another medical condition

Specifiers

Specifier Description
With dissociative symptoms (depersonalization) Experiences of feeling detached from one’s own body, thoughts, or feelings
With dissociative symptoms (derealization) Experiences of unreality, distance, or distortion of surroundings
With delayed expression Full diagnostic criteria not met until at least 6 months after the event

PTSD Symptom Subtypes

Phenotypic variation:

Subtype Dominant Symptoms Common Characteristics
Externalizing Anger, irritability, reckless behavior More common in males; substance use common
Internalizing Depression, numbing, avoidance More common in females; comorbid depression
Dissociative Depersonalization, derealization Higher trauma severity; early-life trauma
Complex Affect dysregulation, negative self-concept, relationship difficulties Chronic, early interpersonal trauma

Acute Stress Disorder (ASD)

Acute stress disorder describes trauma reactions occurring within the first month after exposure.

DSM-5 Criteria

  • Exposure to traumatic event (same criteria as PTSD)
  • Presence of 9 or more symptoms from any of five categories: intrusion, negative mood, dissociation, avoidance, and arousal
  • Symptoms begin or worsen after trauma exposure
  • Duration: 3 days to 1 month
  • Functional impairment

ASD vs. PTSD

Feature ASD PTSD
Timeframe 3 days to 1 month More than 1 month
Dissociative symptoms Required (3+ of 5 types) Specifier only
Predictive of PTSD ~50% of ASD → PTSD N/A
Treatment Early intervention may prevent PTSD Treatment for established disorder

Complex PTSD (C-PTSD)

C-PTSD is recognized in ICD-11 but not as a separate diagnosis in DSM-5 (symptoms captured under PTSD with dissociative features or “other specified trauma- and stressor-related disorder”).

ICD-11 Criteria

C-PTSD includes all core PTSD symptoms plus three additional symptom clusters:

Cluster Description
1. Affect dysregulation Difficulty regulating emotions; extreme emotional responses; emotional numbing
2. Negative self-concept Feelings of worthlessness, shame, guilt; belief of being different or damaged
3. Disturbances in relationships Difficulty sustaining relationships; distrust; difficulty feeling close to others

Risk Factors for C-PTSD

  • Early-onset, prolonged, or repeated trauma
  • Interpersonal trauma (especially by caregivers)
  • Enmeshment in traumatic relationships (captivity, abuse)
  • Lack of protective factors (social support, resources)

Risk and Protective Factors

Pretraumatic Factors

Domain Risk Factors Protective Factors
Demographic Female sex, younger age, lower socioeconomic status Higher education, stable resources
Psychiatric Prior trauma, prior mental disorder, family history Good prior functioning, adaptive coping
Personality Neuroticism, negative affectivity, external locus of control Resilience, optimism, self-efficacy
Cognitive Lower IQ, lower cognitive flexibility Higher cognitive reserve
Developmental Childhood adversity, insecure attachment Secure attachment, supportive family

Peritraumatic Factors

Factor Description
Trauma severity Dose-response relationship: more severe trauma → higher PTSD risk
Perceived threat Higher perceived life threat → increased risk
Peritraumatic dissociation During-trauma dissociation predicts later PTSD
Nature of trauma Interpersonal violence > accidents > natural disasters
Moral injury Events violating moral beliefs increase complexity
Physical injury Traumatic brain injury, severe injury increase risk
Lack of social support Not having support available after trauma increases risk

Posttraumatic Factors

Factor Effect on PTSD
Social support Strong protective factor; predicts recovery
Ongoing life stress Increases risk of chronic PTSD
Maladaptive coping Avoidance, substance use → worse outcomes
Adaptive coping Approach-oriented coping → better outcomes
Secondary stressors Legal, medical, financial stressors compound trauma
Negative social reactions Blame, disbelief from others worsens outcomes

Neurobiology of PTSD

Brain Structure and Function

Region Changes in PTSD Functional Impact
Amygdala Hyperreactivity Increased threat detection; persistent fear
Prefrontal cortex (vmPFC, ACC) Hypofunction; reduced volume Impaired extinction; poor emotion regulation
Hippocampus Reduced volume Contextual memory deficits; difficulty discriminating threat/safety
Insula Altered function Increased interoception; somatic symptoms

Neuroendocrine System

System Alteration Effect
HPA axis Low cortisol (some findings); enhanced negative feedback Altered stress response; immune changes
Norepinephrine Elevated levels; increased sensitivity Hyperarousal; intrusive memories; exaggerated startle
Serotonin Dysregulation Mood symptoms; impulsivity
Endogenous opioids Dysregulation Emotional numbing; dissociation

Fear Conditioning and Extinction

PTSD can be understood as a disorder of fear learning:

  • Fear conditioning: Neutral cues present during trauma become conditioned stimuli that trigger fear
  • Fear generalization: Broadening of triggers beyond original trauma cues
  • Impaired extinction: Difficulty learning that previously threatening cues are now safe (vmPFC dysfunction)
  • Contextual processing deficits: Failure to recognize safety contexts (hippocampal dysfunction)

Evidence-Based Treatments

First-Line Psychological Treatments

Prolonged Exposure (PE):

Component Description
Psychoeducation Understanding trauma reactions, treatment rationale
Breathing retraining Calming skill for managing distress
In vivo exposure Systematic, repeated confrontation with safe but avoided situations
Imaginal exposure Repeated recounting of trauma memory
Processing Discussion of thoughts, feelings following exposure
Duration 8-15 sessions, typically 90 minutes

Cognitive Processing Therapy (CPT):

Component Description
Psychoeducation Impact of trauma, the role of beliefs
Identify stuck points Maladaptive beliefs maintaining PTSD (self-blame, distrust, powerlessness)
Socratic questioning Examining evidence for and against stuck points
Written accounts Writing impact statement and full trauma account (some versions)
Cognitive worksheets Structured practice in challenging maladaptive cognitions
Themes Safety, trust, power/control, esteem, intimacy
Duration 12 sessions, typically 60 minutes

Eye Movement Desensitization and Reprocessing (EMDR):

Component Description
History taking Assessment, treatment planning
Preparation Stabilization, resource development, informed consent
Assessment Identify target memory, negative cognition, positive cognition
Desensitization Bilateral stimulation (eye movements, taps, tones) while focusing on trauma memory
Installation Strengthening positive cognition
Body scan Processing residual physical tension
Closure Stabilization at end of each session
Reevaluation Assessing progress at subsequent sessions
Duration Variable, typically 8-12 sessions

Trauma-Focused Cognitive Behavioral Therapy (TF-CBT):

  • Primarily for children and adolescents
  • Components (PRACTICE): Psychoeducation, Parenting skills, Relaxation, Affect regulation, Cognitive processing, Trauma narrative, In vivo exposure, Conjoint sessions, Enhancing safety

Other Psychological Treatments

Treatment Evidence Description
Brief Eclectic Psychotherapy Moderate Psychodynamic + CBT + creative therapy
Narrative Exposure Therapy Strong (refugees) Short-term for survivors of organized violence
STAIR Narrative Therapy Moderate Skills training + trauma narrative (complex trauma)
Dialectical Behavior Therapy (DBT) Moderate (C-PTSD) Emotion regulation, distress tolerance, interpersonal skills + trauma processing
Present-Centered Therapy Moderate Focus on current life problems rather than trauma
Acceptance and Commitment Therapy Emerging Values-based action, defusion from trauma-related thoughts

Pharmacotherapy

Medication Recommendation Level Notes
Sertraline (SSRI) First-line FDA-approved
Paroxetine (SSRI) First-line FDA-approved
Fluoxetine (SSRI) First-line Strong evidence
Venlafaxine (SNRI) First-line FDA-approved
Prazosin Second-line Trauma nightmares, sleep disturbance (mixed evidence)
Quetiapine (atypical antipsychotic) Second-line Adjunctive; sleep, re-experiencing
Topiramate (anticonvulsant) Second-line (limited) May reduce re-experiencing
Benzodiazepines Not recommended (or caution) May worsen or interfere with recovery
Propranolol (beta-blocker) Investigational Early post-trauma to prevent consolidation (mixed)

Treatment Guidelines Summary

Organization First-Line Second-Line Not Recommended
APA (2023) PE, CPT, EMDR, TF-CBT Brief eclectic, narrative exposure Benzodiazepines
ISTSS (2018) PE, CPT, EMDR, TF-CBT SSRIs/SNRIs Benzodiazepines
VA/DoD (2017) PE, CPT, EMDR SSRIs, SNRIs; present-centered therapy Benzodiazepines
NICE (2018) TF-CBT, EMDR SSRIs, SNRIs Benzodiazepines

Post-Traumatic Growth (PTG)

Post-traumatic growth is the experience of positive psychological change following trauma. Domains include:

Domain Description Examples
Greater appreciation of life Enhanced valuing of each day Reordered priorities; savoring
New possibilities New paths, interests, activities Career change; advocacy; new hobbies
Deeper relationships Closer connections with others Increased empathy; reaching out
Increased personal strength Recognition of one’s resilience “If I survived this, I can survive anything”
Spiritual/existential growth Deepened meaning, faith, or philosophical perspective Greater understanding of suffering, purpose

PTG and PTSD can coexist; growth does not mean absence of distress.

References

  1. American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.). Arlington, VA: APA.
  2. Bisson, J. I., et al. (2021). Psychological therapies for chronic post-traumatic stress disorder. Lancet Psychiatry, 8(2), 181-191.
  3. Foa, E. B., et al. (2019). Prolonged Exposure Therapy for PTSD. Oxford University Press.
  4. Resick, P. A., et al. (2017). Cognitive Processing Therapy for PTSD. Guilford Press.
  5. Shapiro, F. (2018). Eye Movement Desensitization and Reprocessing (EMDR) Therapy (3rd ed.). Guilford Press.
  6. Yehuda, R., et al. (2015). Post-traumatic stress disorder. Nature Reviews Disease Primers, 1, 15057.
  7. National Institute of Mental Health. (2023). Post-Traumatic Stress Disorder. NIMH.
  8. Tedeschi, R. G., & Calhoun, L. G. (2004). Posttraumatic growth. Psychological Inquiry, 15(1), 1-18.